Mercurna was founded in 2017 with the goal to develop truly life-changing medicines.
We consider medicines life-changing if they deliver a cure where previously unavailable, or when cure is not possible, radically improve the quality of life.
There are currently still many indications with such a great unmet medical need. Interestingly, many highly prevalent diseases have closely related pathological mechanisms, such as incorrectly handled inflammation, over-production of reactive oxygen species or aging-related loss of homeostasis.
Based on this similarity, we have designed a modular nanomedicine that can be adapted for a multitude of diseases with ease. It is our aim to use this platform-technology to bring as many highly valuable drugs as possible to the patient.